CASE REPORT: OCCURRENCE OF MALIGNANT NEUROLEPTIC SYNDROME DUE TO THE INTAKE OF RISPERIDONE IN LOW-RISK PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

GHOREYSHI S.A.A.F.; SHAABANI MINA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Advances in Medical and Biomedical Research Year:2007 | Volume:14 | Issue:57 Page(s): 57-59

Download Full-Text

Persian Verion

View:

1,474

Download:

Cites:

Information Journal Paper

Title

CASE REPORT: OCCURRENCE OF MALIGNANT NEUROLEPTIC SYNDROME DUE TO THE INTAKE OF RISPERIDONE IN LOW-RISK PATIENTS

Author(s)

GHOREYSHI S.A.A.F. | SHAABANI MINA | Issue Writer Certificate

Keywords

NEUROLEPTICQ3

MALIGNANTQ3

RISPERIDONQ2

AGED WOMENQ3

Abstract

Narcoleptic MALIGNANT Syndrome (NMS) is a rare but potentially fatal problem induced by the consumption of antipsychotic drugs, especially traditional drugs which are more common in youngsters and males. This paper describes the first reported case of a clinical presentation of NMS (induced by the consumption of RISPERIDONe) in an old woman, who was suffering from psychotic processes. Due to psychotic depression and with differential diagnosis of schizoaffective, the woman had been prescribed a low and medium dosage of RISPERIDONe, but she suddenly and unexpectedly developed clinical NMS. Despite special treatments and services, she passed away after 14 days. In spite of rare universal reports regarding the development of NMS induced by the consumption of RISPERIDONe, so far no occurrence of NMS in AGED WOMEN has been reported.

Cites

No record.

References

No record.

Cite

APA: Copy

GHOREYSHI, S.A.A.F., & SHAABANI, MINA. (2007). CASE REPORT: OCCURRENCE OF MALIGNANT NEUROLEPTIC SYNDROME DUE TO THE INTAKE OF RISPERIDONE IN LOW-RISK PATIENTS. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, 14(57), 57-59. SID. https://sid.ir/paper/61569/en

Vancouver: Copy

GHOREYSHI S.A.A.F., SHAABANI MINA. CASE REPORT: OCCURRENCE OF MALIGNANT NEUROLEPTIC SYNDROME DUE TO THE INTAKE OF RISPERIDONE IN LOW-RISK PATIENTS. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH[Internet]. 2007;14(57):57-59. Available from: https://sid.ir/paper/61569/en

IEEE: Copy

S.A.A.F. GHOREYSHI, and MINA SHAABANI, “CASE REPORT: OCCURRENCE OF MALIGNANT NEUROLEPTIC SYNDROME DUE TO THE INTAKE OF RISPERIDONE IN LOW-RISK PATIENTS,” JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, vol. 14, no. 57, pp. 57–59, 2007, [Online]. Available: https://sid.ir/paper/61569/en

Related Journal Papers